QUÍMICA BIOLÓGICA APLICADA: NUEVOS FÁRMACOS Y BIORREMEDIACIÓN
QUIMBIO-F
Universidad de Jaén
Jaén, EspañaPublikationen in Zusammenarbeit mit Forschern von Universidad de Jaén (11)
2022
2021
-
Small molecule-based enzyme inhibitors in the treatment of primary hyperoxalurias
Journal of Personalized Medicine, Vol. 11, Núm. 2, pp. 1-31
2013
-
In vitro nanoparticle-mediated intracellular delivery into human adipose-derived stem cells
Methods in Molecular Biology, Vol. 1058, pp. 41-47
2012
-
The selective cytotoxic activity in breast cancer cells by an anthranilic alcohol-derived acyclic 5-fluorouracil O,N-acetal is mediated by endoplasmic reticulum stress-induced apoptosis
European Journal of Medicinal Chemistry, Vol. 50, pp. 376-382
2008
-
Anticancer activity of (1,2,3,5-tetrahydro-4,1-benzoxazepine-3-yl)-pyrimidines and -purines against the MCF-7 cell line: Preliminary cDNA microarray studies
Bioorganic and Medicinal Chemistry Letters, Vol. 18, Núm. 4, pp. 1457-1460
-
Synthesis and anticancer activity of (R,S)-9-(2,3-dihydro-1,4-benzoxathiin- 3-ylmethyl)-9H-purines
ChemMedChem, Vol. 3, Núm. 1, pp. 127-135
2007
-
5-fluorouracil derivatives induce differentiation mediated by tubulin and HLA class I modulation
Medicinal Chemistry, Vol. 3, Núm. 3, pp. 233-239
-
A synthetic uracil derivative with antitumor activity through decreasing cyclin D1 and Cdk1, and increasing p21 and p27 in MCF-7 cells
Breast Cancer Research and Treatment, Vol. 105, Núm. 3, pp. 237-246
2006
-
Synthesis and anticancer activity studies of novel 1-(2,3-dihydro-5H-1,4-benzodioxepin-3-yl)uracil and (6′-substituted)-7- or 9-(2,3-dihydro-5H-1,4-benzodioxepin-3-yl)-7H- or 9H-purines
Tetrahedron, Vol. 62, Núm. 50, pp. 11724-11733
2004
-
Actual targets in cytodifferentiation cancer therapy
Current Topics in Medicinal Chemistry, Vol. 4, Núm. 2, pp. 175-202
2000
-
Modulation of myogenic differentiation in a human rhabdomyosarcoma cell line by a new derivative of 5-fluorouracil (QF-3602)
Japanese Journal of Cancer Research, Vol. 91, Núm. 9, pp. 934-940